Skip to main content
Log in

The influence of haemodialysis and haemofiltration on the clearance of Torasemide in renal failure

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The concentration of Torasemide in plasma, dialysate and ultrafiltrate were determined during one haemofiltration and three dialyses. Results show that Torasemide is not significantly eliminated from the blood by these technics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Reference

  1. Lesne M, Clerck-Braun F, Duhoux P, van Ypersele de Strihou Ch (1982) Pharmacokinetic study of torasemide in humans: An overview of its diuretic effect. Int J Clin Pharmacol Ther Toxicol 20 [8]: 382–387

    Google Scholar 

  2. Dodion L, Willems JL (1986) Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency. Eur J Clin Pharmacol 31 [Suppl]: 49–51

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loute, G., Adam, A., Ers, P. et al. The influence of haemodialysis and haemofiltration on the clearance of Torasemide in renal failure. Eur J Clin Pharmacol 31 (Suppl 1), 53–55 (1986). https://doi.org/10.1007/BF00541468

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541468

Key words

Navigation